GlassScriptPhysician profile
William Mustas
NPI 1629080932
$4,871.53
in general payments reported to CMS, 2019-2025
25 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $836 · 2022: $1,814 · 2023: $1,483 · 2024: $604 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,921 · Education: $283 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.07 |
| Education | $282.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,485.09 | 2021-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $444.95 | 2021-2024 | Erleada, Akeega |
| Pfizer INC. | $361.33 | 2021-2024 | |
| Teleflex LLC | $271.59 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $266.05 | 2021-2022 | |
| Halozyme INC | $250.08 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $214.54 | 2022-2025 | |
| Antares Pharma, INC. | $209.51 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $206.73 | 2023-2024 | Gemtesa |
| Axonics, INC. | $171.40 | 2021-2024 | Axonics |
| Rochester Medical Corporation | $169.56 | 2021-2022 | |
| Abbvie INC. | $154.00 | 2022-2025 | |
| Coloplast Corp | $138.71 | 2021-2023 | Speedicath |
| Olympus America INC. | $138.35 | 2022-2025 | Itind System |
| Urovant Sciences INC | $93.13 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $64.26 | 2021-2022 | |
| 180 Medical, INC. | $55.95 | 2021-2022 | |
| Blue Earth Diagnostics | $38.83 | 2021 | |
| Novartis Pharmaceuticals Corporation | $26.89 | 2025 | |
| Bluewind Medical | $23.18 | 2024 | Revi |
| Merck Sharp & Dohme LLC | $20.15 | 2025 | Keytruda |
| Convatec INC. | $19.42 | 2022 | |
| Procept Biorobotics Corporation | $17.22 | 2022 | |
| Accord Healthcare, INC. | $16.66 | 2022 | |
| Clarus Therapeutics INC. | $13.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mustas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.